MedTech Dive November 29, 2023
Nick Paul Taylor

The actions include using the Defense Production Act to enable investment in U.S. manufacturing of essential medicines and medical countermeasures, such as diagnostics.

Dive Brief:

  • President Joe Biden unveiled a list of new actions Monday to strengthen U.S. supply chains, including using the Defense Production Act (DPA) to enable investment in the manufacturing of medicines and medical countermeasures, such as diagnostic tests and personal protective equipment.
  • Biden, who took office as the COVID-19 pandemic was disrupting the flow of goods, framed the actions as a way to strengthen supply chains, enable reliable deliveries for businesses and create U.S. jobs. Along with the announcement, Biden held the inaugural meeting of a new cabinet-level White House council on logistics resilience
  • Medtech...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Medical Devices, Pharma, Pharma / Biotech, Supply Chain, Technology
Medicare Telehealth, Hospital-at-Home Flexibilities In Danger As Partial Government Shutdown Threat Rises
Federal Discretionary Spending To Address Substance Use Disorders: How Big A Shift?
White House and Congress Turn Focus to Health Policy
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
OIG Recounts Historic Recovery Numbers in Its Latest Semiannual Report to Congress

Share Article